(NASDAQ:ABP), BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) — Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid tumors, today announced that its lead multispecific antibody oncology program, ABP-102 / CT-P72, was featured in a presentation by its global collaboration partner, Celltrion, at the 2026 J.P. Morgan Healthcare Conference. […]

Pune, India, Jan. 15, 2026 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading MCPMS vendors. Metapack, a leading delivery platform, has received strong ratings across technology excellence and customer impact. QKS Group announced today that it has named Metapack as a leader in the SPARK Matrix(TM): Multi-Carrier

(NASDAQ:TLN),(LSE:BPT.L), HOUSTON, Jan. 15, 2026 (GLOBE NEWSWIRE) — Talen Energy Corporation (“Talen,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, announced it has signed definitive agreements to add approximately 2.6 gigawatts of natural gas generation capacity to Talen's portfolio through the acquisition of the Waterford Energy Center (“Waterford”) and Darby Generating Station (“Darby”)

(NasdaqGM:AXSM), NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first patient has been dosed in the FORWARD Phase 3 trial of AXS-14 (esreboxetine) for the management of fibromyalgia. FORWARD (Fibromyalgia Response

LONDON and MILAN, Jan. 15, 2026 (GLOBE NEWSWIRE) — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs), has announced the completion of enrollment in LUCE-1, their Phase 1/2 first-in-human clinical trial evaluating AAVB-081 for the treatment of retinitis pigmentosa associated with Usher syndrome type 1B (USH1B). LUCE-1 is a

(Neo:VRNO.NE),(OTC US:VRNO),(OtherOTC:VRNO), Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, 2029 CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced an amendment to its existing $75,000,000 revolving credit facility agented by

(TSX-V:SAE),(OTC US:SBLRF),(Other OTC:SBLRF), VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV:SAE | OTCQB:SBLRF) is pleased to announce that it has entered into a binding letter agreement with an arm's length party, with the intent to enter into a definitive option agreement to acquire a 100% interest

SCOTTSDALE, Ariz., Jan. 15, 2026 (GLOBE NEWSWIRE) — Out of twenty firms that were nominated, The Miller Group – Miller Capital is extremely pleased to be voted Arizona Foothills Magazine's “Best of Our Valley” – Best Investment Firm for the eighth time, including 2013. Miller Capital also earned a top two position in 2019, 2018,

(NASDAQ:MRCY), ANDOVER, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, today announced contract awards totaling more than $60 million for work associated with two critical U.S. space and strategic weapons programs. In December, Mercury was awarded a development contract

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — VapeAway(R) LLC, a healthcare company focused on developing innovative solutions for nicotine dependence due to vaping, today announced that the first patient has been enrolled in its clinical study evaluating its patented VapeAway(R) filter (technology) and fix bar (Fix+Bar) device system, a non-pharmacologic (“drug-free”) device designed to